Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases

British Journal of Surgery

Volumn 100, Issue 6, 2013, Pages 820-826

  Hamady, Z Z R ^a,b   Rees, M ^a   Welsh, F K ^a   Toogood, G J ^b   Prasad, K R ^b   John, T K ^a   Lodge, J P A ^b  

^a North Hampshire County Hospital   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COLORECTAL TUMOR; EPIDEMIOLOGY; FATTY LIVER; FEMALE; HUMAN; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; POSTOPERATIVE COMPLICATION; TUMOR RECURRENCE;

AGED; COLORECTAL NEOPLASMS; EPIDEMIOLOGIC METHODS; FATTY LIVER; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS;

EID: 84875844807     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9057     Document Type: Article

References (22)

1. Joshu CE, Mondul AM, Menke A, Meinhold C, Han M, Humphreys EB, et al., Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res (Phila) 2011; 4: 544-551.
2. World Cancer Research Fund (WCRF) International. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. WCRF International: Washington, 2007.
3. Patlak M, Nass SJ,. The Role of Obesity in Cancer Survival and Recurrence: Workshop Summary. National Academy Press, 2012. http://www.nap.edu/ catalog.php?record-id=13348 [accessed 1 August 2012].
4. Shen Z, Ye Y, Bin L, Yin M, Yang X, Jiang K, et al., Metabolic syndrome is an important factor for the evolution of prognosis of colorectal cancer: survival, recurrence, and liver metastasis. Am J Surg 2010; 200: 59-63.
5. Hsiao PJ, Kuo KK, Shin SJ, Yang YH, Lin WY, Yang JF, et al., Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gastroenterol Hepatol 2007; 22: 2118-2123.
6. VanSaun MN, Lee IK, Washington MK, Matrisian L, Gorden DL,. High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am J Pathol 2009; 175: 355-364.
7. Takuma Y, Nouso K, Makino Y, Saito S, Takayama H, Takahara M, et al., Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma. Liver Int 2007; 27: 620-626.
8. Vendemiale G, Grattagliano I, Caraceni P, Caraccio G, Domenicali M, Dall'Agata M, et al., Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 2001; 33: 808-815.
9. Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A,. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol 2004; 68: 1003-1015.
10. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al., Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149: 713-724.
11. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP,. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol 2006; 32: 557-563.
12. D'Agostino RB Jr,. Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Stat Med 1998; 17: 2265-2281.
13. Ohki T, Tateishi R, Shiina S, Goto E, Sato T, Nakagawa H, et al., Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut 2009; 58: 839-844.
14. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, et al., Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006; 98: 1647-1654.
15. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C,. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res 2010; 16: 1884-1893.
16. Haydon AM, MacInnis RJ, English DR, Giles GG,. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 2006; 55: 62-67.
17. Borena W, Strohmaier S, Lukanova A, Bjorge T, Lindkvist B, Hallmans G, et al., Metabolic risk factors and primary liver cancer in a prospective study of 578 700 adults. Int J Cancer 2012; 131: 193-200.
18. Hursting SD, Berger NA,. Energy balance, host-related factors, and cancer progression. J Clin Oncol 2010; 28: 4058-4065.
19. Aggarwal BB, Vijayalekshmi R, Sung B,. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 2009; 15: 425-430.
20. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM,. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-298.
21. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, et al., Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009; 250: 691-697.
22. Angliviel B, Benoist S, Penna C, El Hajjam M, Chagnon S, Julié C, et al., Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases. Ann Surg Oncol 2009; 16: 1247-1253.